West Pharmaceutical Services EBITDA Margin 2010-2023 | WST
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for West Pharmaceutical Services (WST) over the last 10 years. The current EBITDA margin for West Pharmaceutical Services as of December 31, 2023 is .
| West Pharmaceutical Services EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$2.95B |
$0.81B |
27.59% |
| 2023-09-30 |
$2.93B |
$0.78B |
26.58% |
| 2023-06-30 |
$2.87B |
$0.78B |
27.24% |
| 2023-03-31 |
$2.88B |
$0.82B |
28.54% |
| 2022-12-31 |
$2.89B |
$0.86B |
29.62% |
| 2022-09-30 |
$2.91B |
$0.91B |
31.35% |
| 2022-06-30 |
$2.93B |
$0.91B |
30.97% |
| 2022-03-31 |
$2.88B |
$0.89B |
30.81% |
| 2021-12-31 |
$2.83B |
$0.87B |
30.85% |
| 2021-09-30 |
$2.68B |
$0.80B |
29.87% |
| 2021-06-30 |
$2.52B |
$0.72B |
28.46% |
| 2021-03-31 |
$2.33B |
$0.61B |
26.14% |
| 2020-12-31 |
$2.15B |
$0.52B |
24.08% |
| 2020-09-30 |
$2.04B |
$0.48B |
23.36% |
| 2020-06-30 |
$1.95B |
$0.44B |
22.66% |
| 2020-03-31 |
$1.89B |
$0.42B |
22.13% |
| 2019-12-31 |
$1.84B |
$0.40B |
21.73% |
| 2019-09-30 |
$1.79B |
$0.39B |
21.65% |
| 2019-06-30 |
$1.77B |
$0.38B |
21.61% |
| 2019-03-31 |
$1.75B |
$0.36B |
20.68% |
| 2018-12-31 |
$1.72B |
$0.35B |
20.08% |
| 2018-09-30 |
$1.71B |
$0.34B |
19.74% |
| 2018-06-30 |
$1.68B |
$0.34B |
20.20% |
| 2018-03-31 |
$1.63B |
$0.32B |
19.59% |
| 2017-12-31 |
$1.60B |
$0.32B |
20.19% |
| 2017-09-30 |
$1.57B |
$0.31B |
19.99% |
| 2017-06-30 |
$1.55B |
$0.30B |
19.35% |
| 2017-03-31 |
$1.54B |
$0.32B |
20.65% |
| 2016-12-31 |
$1.51B |
$0.29B |
18.89% |
| 2016-09-30 |
$1.49B |
$0.28B |
18.76% |
| 2016-06-30 |
$1.46B |
$0.22B |
15.40% |
| 2016-03-31 |
$1.43B |
$0.20B |
14.09% |
| 2015-12-31 |
$1.40B |
$0.22B |
15.63% |
| 2015-09-30 |
$1.39B |
$0.22B |
15.60% |
| 2015-06-30 |
$1.40B |
$0.27B |
18.90% |
| 2015-03-31 |
$1.41B |
$0.28B |
19.91% |
| 2014-12-31 |
$1.42B |
$0.27B |
19.13% |
| 2014-09-30 |
$1.42B |
$0.26B |
18.66% |
| 2014-06-30 |
$1.40B |
$0.26B |
18.49% |
| 2014-03-31 |
$1.38B |
$0.25B |
17.79% |
| 2013-12-31 |
$1.37B |
$0.25B |
18.12% |
| 2013-09-30 |
$1.35B |
$0.24B |
17.88% |
| 2013-06-30 |
$1.31B |
$0.23B |
17.18% |
| 2013-03-31 |
$1.29B |
$0.22B |
16.74% |
| 2012-12-31 |
$1.27B |
$0.21B |
16.73% |
| 2012-09-30 |
$1.24B |
$0.21B |
16.53% |
| 2012-06-30 |
$1.23B |
$0.20B |
16.59% |
| 2012-03-31 |
$1.21B |
$0.20B |
16.24% |
| 2011-12-31 |
$1.19B |
$0.19B |
15.52% |
| 2011-09-30 |
$1.17B |
$0.17B |
14.05% |
| 2011-06-30 |
$1.15B |
$0.16B |
14.25% |
| 2011-03-31 |
$1.13B |
$0.17B |
14.67% |
| 2010-12-31 |
$1.11B |
$0.16B |
14.84% |
| 2010-09-30 |
$1.12B |
$0.18B |
15.97% |
| 2010-06-30 |
$1.11B |
$0.18B |
16.14% |
| 2010-03-31 |
$1.09B |
$0.18B |
16.18% |
| 2009-12-31 |
$1.06B |
$0.17B |
15.64% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$27.478B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
